Russell Frank Company’s Accretive Health AH Stock Holding History

Russell Frank Company’s Portfolio AH Stock Details AH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-101,800	Closed	-$814K	–	2970
2014 Q1	$814K	Buy	+101,800	New	+$901K	﹤0.01%	2178
2013 Q4	–	Sell	-4,066	Closed	-$37K	–	3417
2013 Q3	$37K	Sell	4,066 -100,054	-96%	-$995K	﹤0.01%	3165
2013 Q2	$1.13M	Buy	+104,120	New	+$1.1M	﹤0.01%	2008

Other funds holding AH

JRP

Jasper Ridge Partners Menlo Park, California $4.49B AUM 18.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

RMC

Regis Management Company Menlo Park, California $331M AUM 14.13% 1-Year Est. Return

BCM

Breithorn Capital Management New York $141M AUM 41.82% 1-Year Est. Return

ECM

EII Capital Management New York $774K AUM 22.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

MIM

Merion Investment Management Bay Harbor Islands, Florida $1.26M AUM 28.57% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

SCM

Stonebridge Capital Management Los Angeles, California $220M AUM

Russell Frank Company's AH Position: Q2 2014 in Review

Russell Frank Company sold out of Accretive Health (AH) in Q2 2014, closing a stake of 101,800 shares — an estimated $814K sold.

Russell Frank Company first reported a position in AH in Q2 2013 and held it in 3 quarters. The position peaked at $1.13M in Q2 2013. 12 funds tracked by Wall St. Rank hold AH as of Q2 2014.

Russell Frank Company reported no remaining Accretive Health position as of Q2 2014 after selling out during the quarter.
Russell Frank Company sold 101,800 Accretive Health shares in Q2 2014, an estimated $814K.
Russell Frank Company first reported a position in Accretive Health in Q2 2013 and held it in 3 quarters.
Russell Frank Company's Accretive Health position peaked at $1.13M in Q2 2013.
12 funds tracked by Wall St. Rank held Accretive Health as of Q2 2014.

Based on Russell Frank Company's 13F filing for Q2 2014, filed 14 Aug 2014.